SKK
ANAC

Shepherd Kaplan Krochuk’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-27,711
Closed -$465K – 708
2013
Q4 		$465K Hold
27,711
– – 0.06% 211
2013
Q3 		$294K Sell
27,711
-9,069
-25% -$79.3K 0.05% 301
2013
Q2 		$206K Buy
+36,780
New +$223K 0.04% 423

Other funds holding ANAC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Shepherd Kaplan Krochuk's ANAC Position: Q1 2014 in Review

Shepherd Kaplan Krochuk sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2014, closing a stake of 27,711 shares — an estimated $465K sold.

Shepherd Kaplan Krochuk first reported a position in ANAC in Q2 2013 and held it in 3 quarters. The position peaked at $465K in Q4 2013. 105 funds tracked by Wall St. Rank hold ANAC as of Q1 2014.

  • Shepherd Kaplan Krochuk reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 27,711 ANACOR PHARMACEUTICALS INC COM shares in Q1 2014, an estimated $465K.
  • Shepherd Kaplan Krochuk first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 3 quarters.
  • Shepherd Kaplan Krochuk's ANACOR PHARMACEUTICALS INC COM position peaked at $465K in Q4 2013.
  • 105 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2014, filed 15 May 2014.